Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cacoub

Showing results (331-340 of 375) with videos related to

Pageof 38
Sort By:
British Journal of Rheumatology|August 1, 1993
Hepatitis C virus and essential mixed cryoglobulinaemiaP Cacoub, L Musset, F Lunel Fabiani, et al.
Ocular Immunology and Inflammation|May 25, 2017
Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot StudyC Bottin, A Fel, N Butel, et al.
Arthritis and Rheumatism|October 11, 2001
Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemiaP Cacoub, C Renou, G Kerr, et al.
Epidemiology and Infection|April 9, 2005
Management of chronic hepatitis C in French departments of internal medicine and infectious diseasesP Cacoub, I Goderel, P Morlat, et al.
AIDS Care|June 13, 2013
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study)E Rosenthal, L Piroth, E Cua, et al.
Arthritis Care & Research|July 29, 2010
Azathioprine in severe uveitis of Behçet's diseaseD Saadoun, B Wechsler, C Terrada, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Gut|June 16, 1999
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virusP Cresta, L Musset, P Cacoub, et al.
Clinical and Experimental Immunology|March 8, 2002
Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemiaG Kaplanski, V Marin, T Maisonobe, et al.
Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
Pageof 38

Showing results (331-340 of 375) with videos related to

Sort By:
Pageof 38
British Journal of Rheumatology|August 1, 1993
Hepatitis C virus and essential mixed cryoglobulinaemiaP Cacoub, L Musset, F Lunel Fabiani, et al.
Ocular Immunology and Inflammation|May 25, 2017
Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot StudyC Bottin, A Fel, N Butel, et al.
Arthritis and Rheumatism|October 11, 2001
Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemiaP Cacoub, C Renou, G Kerr, et al.
Epidemiology and Infection|April 9, 2005
Management of chronic hepatitis C in French departments of internal medicine and infectious diseasesP Cacoub, I Goderel, P Morlat, et al.
AIDS Care|June 13, 2013
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study)E Rosenthal, L Piroth, E Cua, et al.
Arthritis Care & Research|July 29, 2010
Azathioprine in severe uveitis of Behçet's diseaseD Saadoun, B Wechsler, C Terrada, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Gut|June 16, 1999
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virusP Cresta, L Musset, P Cacoub, et al.
Clinical and Experimental Immunology|March 8, 2002
Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemiaG Kaplanski, V Marin, T Maisonobe, et al.
Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
Pageof 38